Lv1
90 积分 2023-07-11 加入
Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype
19天前
已完结
Diagnostic accuracy and challenges of intraoperative frozen section evaluation for axillary sentinel lymph node biopsy and breast margins
27天前
已完结
Patient-centered Care and Integrated Practice Units: Embracing the Breast Care Continuum
29天前
已关闭
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study
1个月前
已完结
Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons
1个月前
已完结
Characterization of Large Genomic Rearrangements in BRCA1 and BRCA2 Genes in a Chinese High-Risk Cohort
3个月前
已完结
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy
5个月前
已完结
PARP inhibitor-based combination therapies: enriching synergistic forces against BRCA-mutated metastatic breast cancer
5个月前
已完结
Benefits of Breast Cancer Screening and Treatment on Mortality
5个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
9个月前
已完结
皖公网安备34019202002308
